Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Risk factors for infection in patients undergoing knee arthroscopy: a systematic review and meta-analysis.

The Journal of hospital infection·2024

Same author

[Application of Padua prediction score and serum albumin level in evaluating venous thromboembolism in rheumatic inpatients].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2023

Same author

[Honokiol reduces oxidative stress by activating the SIRT3-MnSOD2 pathway to alleviate hypertriglyceridemia-induced acute pancreatitis in rats].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2023

Same author

The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread.

Nature communications·2023

Same author

A new biofeedback device to improve adherence to pelvic floor muscle training in women with urinary incontinence: a randomised controlled pilot trial (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2022

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

[The association between microsatellite polymorphism of alpha 1-antichymotrypsin gene and Alzheimer's disease].

S Jiang¹, S Lin, G Tang

¹Shanghai Institute of Mental Health, Shanghai 200030, China.

Zhonghua Yi Xue Za Zhi

|November 22, 2001

Summary

This summary is machine-generated.

The alpha 1-antichymotrypsin (AACT) A6 allele may reduce Alzheimer's disease risk in Shanghai Han Chinese. This protective effect is observed specifically in individuals without the apolipoprotein E (ApoE) epsilon 4 allele.

More Related Videos

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Published on: May 20, 2024

Related Experiment Videos

Last Updated: Jun 24, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Published on: May 20, 2024

Area of Science:

Genetics
Neuroscience
Molecular Biology

Context:

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with complex genetic underpinnings.
The alpha 1-antichymotrypsin (AACT) gene and apolipoprotein E (ApoE) gene are implicated in AD pathogenesis.
Understanding genetic associations is crucial for identifying disease mechanisms and potential therapeutic targets.

Purpose:

To investigate the association between microsatellite polymorphism in the AACT gene and Alzheimer's disease (AD) in the Shanghai Han Chinese population.
To determine the influence of the apolipoprotein E (ApoE) epsilon 4 allele on the relationship between AACT gene polymorphism and AD.
To explore potential protective or risk factors for AD in a specific ethnic group.

Summary:

Microsatellite polymorphism analysis of the AACT gene was performed in 63 AD cases and 62 controls using amplified fragment length polymorphism (Amp-FLP).
A significant decrease in AACT gene alleles A6 and A10 was observed in AD patients.
The AACT A6 allele showed a negative association with AD, particularly in individuals lacking the ApoE epsilon 4 allele.

Impact:

The AACT A6 allele may confer a protective effect against Alzheimer's disease in the Shanghai Han Chinese population.
This protective association is contingent on the absence of the ApoE epsilon 4 allele, suggesting gene-gene interactions in AD risk.
Findings contribute to the understanding of genetic heterogeneity in Alzheimer's disease and may inform future research on targeted prevention strategies.